Mindup israel4/30/2023 Stalmans works extensively with Nano Retina on the development of the surgical procedure and the clinical aspects of the device. His professional interests are vitreoretinal surgery, surgical instrument and device development and pharmacological vitreolysis. Stalmans was the principal investigator of the phase II ocriplasmin clinical trial and coordinating investigator of the MIVI TRUST phase III trials (MIVI 6 and MIVI 7). He has presented at various national and international meetings. Stalmans is a member of AAO, ARVO, EVER, the Belgian Society of Ophthalmology, ASRS, EVRS, and EURETINA and has organized the international Leuven Retina Meeting in 2011, 20. He became a staff member at UZ Leuven in 2000 and Associate Professor at the KU Leuven in 2001. After completion of his residency-in-training in ophthalmology at UZ Leuven, he worked for one year as a vitreoretinal fellow at the Eye Hospital Rotterdam. Peter Stalmans is a staff member of the Department of Ophthalmology at UZ Leuven and Associate Professor at the KU Leuven. Serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology and of Ophthalmologica. Published more than 450 papers in peer reviewed journals, and contributed multiple chapters to ophthalmology textbooks. She serves on advisory boards of most large current pharmaceutical companies. She also took a pivotal part in the early development of the Port Delivery System - an innovative, FDA approved, intraocular drug delivery system. She has been leading several cutting-edge technologies implemented in large scale clinical trials and in clinical setting: the home OCT, a first-of a -kind artificial intelligence-enabled algorithm for monitoring retinal diseases, utilizing an OCT device in the patient's own home, and the development of a technology implementing virtual reality in vitreoretinal surgery in order to replace the standard operating microscope. Main field of interest is the investigation of drug administration and toxicity to the retina, early detection of macular degeneration and home monitoring of retinal disease. Please join us on Tuesday, June 26 from 9:00 a.m.Anat Loewenstein, MD, MHA, Professor of Ophthalmology, Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center, Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, President of the Israeli Ophthalmological Society and the General Secretary of the Euretina board. for a tour of the world’s most innovative places and a discussion on what today’s technology trends mean for the future security and prosperity of the United States. During this event, we will launch a new report: The Global Innovation Sweepstakes: A Quest to Win the Future. The Atlantic Council’s Scowcroft Center for Strategy and Security, in partnership with Qualcomm, embarked on a global tour of technology hubs to determine which ones are at the cutting edges of tech-based innovation-and which are at risk of falling behind. Soffer is on the board of director of the MindUp digital health incubator. Our researchers visited nearly a dozen countries and spoke with almost two hundred experts. Soffer has published over 50 papers in referred journals and conferences. Eurovision 1981 United Kingdom - Bucks Fizz - Making your mind up. How do the United States and China compare? Can Europe rise to the challenge? Why are small states often the most innovative? This new report seeks to answer these questions-and others raised by the unfolding technological revolution. Israel Israel Eden Alene Set Me Free Final Eurovision Song Contest. MindUP the Digital Health Incubator July 21 Our goal is to disrupt the healthcare sector by identifying companies that provide preventive, predictive, proactive, or personalized solutions that impact quality, cost, and access to healthcare. MindUP - The Digital Health Incubator on LinkedIn: Our portfolio of companies - MindUP. MindUP, Haifa's Digital Health Incubator is a venture of Medtronic, IBM, Pitango Venture Capital, Impact 1st Investments and Rambam Medical Center, that recently won the tender published by Israel's Office of the Chief Scientist. It also provides policy recommendations for research and development, skills training, technology transfer, diversity, education, and more.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |